Drug and Alcohol Testing


News

  • Cleveland Designated a DEA 360 City

    The agency is offering additional resources focused on preventing drug abuse with a particular emphasis on education about the dangers of opioids. The effort includes a website, a public awareness campaign, after-school activities, and free presentations to schools and workplaces. More News

  • Cannabis Edibles to Be Sold in Canada by Mid-December

    A limited selection of products will appear gradually in physical or online stores no earlier than mid-December 2019, Health Canada reported. Federal license holders must provide 60 days' notice to Health Canada of their intent to sell new products. More News

  • Michigan Counts 202 Active Medical Marijuana Licenses

    The Marijuana Regulatory Agency held its first public meeting June 13 in Lansing, with agency leaders and managers presenting reports and discussing their operations. Executive Director Andrew Brisbo announced that the next three scheduled public meetings of the agency will coincide with work groups and will be held Aug. 29 in Detroit, Oct. 28 in Traverse City, and Dec. 9 in Flint. More News

  • Colorado Behavioral Health Task Force Meeting July 1

    The task force will evaluate Colorado's behavioral health system and write a statewide strategic blueprint to reform the system with the goal of allowing every Coloradan experiencing behavioral health needs to receive timely, high-quality services in his or her community. More News

  • Ohio BWC Dropping Coverage of Oxycontin

    The Ohio Bureau of Workers' Compensation will no longer pay for Oxycontin or generic sustained-release oxycodone tablets for workers who suffer on-the-job injuries on or after June 1, 2019. Injured workers who are currently on those medications will have until Dec. 31 to discontinue their use or switch to a different product on the state agency's formulary. More News

  • AMA Opioid Task Force Issues New Recommendations

    "We need help from policy makers to ensure that more people have access to treatment. Physicians are responding to the epidemic and we are seeing results: a reduction in opioid prescribing of 33 percent since 2013, increased use of prescription drug monitoring programs, enhanced education, and greater co-prescribing of naloxone," said AMA President-elect Dr. Patrice A. Harris, who is the task force's chair. "But we cannot enforce parity laws or eliminate administrative barriers without the help of state and federal authorities, and that's what is limiting treatment now." More News


Webinars


Videos

  • Marijuana Safety Road Trip

    NFPA Journal's Jesse Roman takes a trip to Colorado in 2016 to report on the the burgeoning commercial marijuana industry and how public agencies are battling to ensure that marijuana grow and extraction facilities are safe for employees, firefighters, and the public.

  • Boating Safety PSA

    This boating safety public service announcement detailing various important topics to keep everyone safe on the water was created by U.S. Coast Guard Auxiliarist David Glaser.

  • Bath Salts: It's not a fad... It's a Nightmare

    Bath salts are a non-regulated designer drug comprised of a synthetic cathinone, or amphetamine, that can have dangerous and debilitating effects on those who use them. The adverse health effects from bath salt use can range from agitation to lack of appetite, kidney failure, muscle spasms, severe paranoid delusions, and psychosis. Several cases of long-term patient hospitalization and suicide have been reported. For more information from Navy Medicine on Synthetic Drugs and your health, visit http://go.usa.gov/gwhW.


Bulwark Quiz